The Medical Devices sector report, “Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update' provides comprehensive information about the Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Aortic Stent grafts are used to reinforce a weaken aorta to prevent ruptures.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Aortic Stent grafts are used to reinforce a weaken aorta to prevent ruptures.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Aortic Stent Grafts under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Aortic Stent Grafts and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Aortic Stent Grafts under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Aortic Stent Grafts - Pipeline Products under Development by Companies
5 Aortic Stent Grafts Companies and Product Overview
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Affluent Medical SASU
- Angiolutions UG
- APT Medical Inc
- Artivion Inc
- Ascyrus Medical LLC
- Beijing Tianzhu Ruichang Medical Technology Co Ltd
- BiFlow Medical Ltd
- BioQ Devices Pty Ltd
- Cook Medical Inc
- Cytograft Tissue Engineering Inc (Inactive)
- Endologix LLC
- Endoluminal Sciences Pty Ltd.
- EndoSpan Ltd
- Evasc Medical Systems Corp
- Hadassah Medical Center
- Hangzhou Endonom Medtech Co Ltd
- Intressa Vascular SA
- Johns Hopkins University
- JOTEC GmbH
- Kawasumi Laboratories Inc
- Lifetech Scientific (Shenzhen) Co Ltd
- Lombard Medical Technologies Inc.
- Lombard Medical Technologies Ltd (Inactive)
- Lundquist
- Medtronic Plc
- Merit Medical Systems Inc
- MicroPort Scientific Corp
- PerMed Biomedical Engineering Co Ltd
- Red Vascular Technologies LLC
- Shanghai MicroPort Endovascular MedTech Group Co Ltd
- Sree Chitra Tirunal Institute for Medical Sciences & Technology
- St. Jude Medical LLC
- Terumo Aortic
- Terumo Corp
- The Lundquist Institute
- TriVascular Inc
- University of Arizona
- University of Colorado Denver
- University of Limerick
- University of Nebraska Medical Center
- Venus Medtech Hangzhou Inc
- W. L. Gore & Associates Inc
- Zylox-Tonbridge Medical Technology Co Ltd
